Welcome to the Australian Scleroderma Interest Group (ASIG) website. Since its inception in 2007 to facilitate state-of-the-art care and research in scleroderma, ASIG has made dozens of impactful contributions to inform management of this complex and at times devastating multi-organ autoimmune disease. Through leadership of international research projects, together with nationwide and global inter-disciplinary collaborations, ASIG is now recognised worldwide as a leader in the field of scleroderma.
ASIG is proud to foster and facilitate the training and career development of new and emerging investigators. ASIG achievements have been recognised with numerous awards and prizes including the Australian Rheumatology Association’s Collaborative Research Prize in 2018.
Now well into our second decade, we look forward to great things to come as we work with our patient support and advocacy partners Scleroderma Victoria and Scleroderma Australia to bring hope of a better future for those living with scleroderma.